These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 913112)

  • 1. Collagen bands: a new vaginal delivery system for contraceptive steroids.
    Victor A; Nash HA; Jackanicz TM; Johansson ED
    Contraception; 1977 Aug; 16(2):125-35. PubMed ID: 913112
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles.
    Victor A; Johansson ED
    Contraception; 1976 Aug; 14(2):215-26. PubMed ID: 949897
    [No Abstract]   [Full Text] [Related]  

  • 3. Contraceptive rings; self-administered treatment governed by bleeding.
    Victor A; Johansson ED
    Contraception; 1977 Aug; 16(2):137-47. PubMed ID: 562247
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
    Mishell DR; Moore DE; Roy S; Brenner PF; Page MA
    Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral plasma levels of d-norgestrel in women after oral administration of d-norgestrel and when using intravaginal rings impregnated with dl-norgestrel.
    Victor A; Edqvist LE; Lindberg P; Elamsson K; Johansson ED
    Contraception; 1975 Sep; 12(3):261-78. PubMed ID: 1164846
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleeding and ovulation control with use of a small contraceptive vaginal ring releasing levonorgestrel and estradiol.
    Toivonen J; Lähteenmäki P; Luukkainen T
    Contraception; 1979 Jul; 20(1):11-8. PubMed ID: 477313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of a contraceptive vaginal ring governed by the pattern of individual uterine bleeding.
    Toivonen J; Lähteenmäki P; Luukkainen T
    Contraception; 1979 Apr; 19(4):401-9. PubMed ID: 455988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraception with d-norgestrel silastic rods. Plasma levels of d-norgestrel and influence on the ovarian function.
    Weiner E; Johansson ED
    Contraception; 1976 Nov; 14(5):551-62. PubMed ID: 987891
    [No Abstract]   [Full Text] [Related]  

  • 9. A D-norgestrel-releasing IUD.
    Nilsson CG; Johansson ED; Luukkainen T
    Contraception; 1976 Apr; 13(4):503-14. PubMed ID: 1253602
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
    Alvarez F; Faundes A; Johansson E; Coutinho E
    Fertil Steril; 1983 Jul; 40(1):120-3. PubMed ID: 6407876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats.
    Doyle LL
    Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performances and endocrine profilles with contraceptive vaginal rings containing d-norgestrel.
    Mishell DR; Roy S; Moore DE; Brenner PF; Page MA; Gentzschein E; Fisk PD
    Contraception; 1977 Dec; 16(6):625-36. PubMed ID: 606502
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings loaded with levonorgestrel.
    Wadsworth PF; Heywood R; Allen DG; Hossack DJ; Sortwell RJ; Walton RM
    Contraception; 1979 Dec; 20(6):559-67. PubMed ID: 119606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
    Moore DE; Roy S; Stanczyk FZ; Mishell DR
    Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel].
    Elkik F; Basdevant A; Corvol P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1737-9. PubMed ID: 3938250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration.
    Granger LR; Roy S; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conception control by vaginal administration of pills containing ethinyl estradiol and dl-norgestrel.
    Coutinho EM; da Silva AR; Carreira C; Rodrigues V; Gonçalves MT
    Fertil Steril; 1984 Sep; 42(3):478-81. PubMed ID: 6381103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary and gonadal function during the use of norgestrelestradiol vaginal rings.
    Toivonen J; Lähteenmäki P; Luukkainen T
    Contraception; 1978 Sep; 18(3):201-11. PubMed ID: 720065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
    Miller JF; Fotherby K; Bye PG; Elstein M
    Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.